A detailed history of Wells Fargo & Company transactions in Dario Health Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 100 shares of DRIO stock, worth $100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 313 68.05%
Holding current value
$100
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.09 - $1.9 $232 - $404
-213 Reduced 68.05%
100 $0
Q1 2024

May 10, 2024

BUY
$1.4 - $2.55 $5 - $10
4 Added 1.29%
313 $0
Q4 2023

Feb 09, 2024

SELL
$1.0 - $3.39 $1,990 - $6,746
-1,990 Reduced 86.56%
309 $0
Q3 2023

Nov 13, 2023

BUY
$2.6 - $4.23 $5,278 - $8,586
2,030 Added 754.65%
2,299 $7,000
Q2 2023

Aug 15, 2023

SELL
$3.2 - $4.33 $716 - $969
-224 Reduced 45.44%
269 $1,000
Q1 2023

May 12, 2023

SELL
$3.79 - $6.22 $560 - $920
-148 Reduced 23.09%
493 $2,000
Q4 2022

Feb 13, 2023

BUY
$3.53 - $5.49 $21 - $32
6 Added 0.94%
641 $2,000
Q3 2022

Nov 14, 2022

BUY
$3.74 - $7.09 $11 - $21
3 Added 0.47%
635 $3,000
Q2 2022

Aug 12, 2022

SELL
$4.33 - $7.45 $11,561 - $19,891
-2,670 Reduced 80.86%
632 $4,000
Q1 2022

May 16, 2022

SELL
$5.84 - $13.61 $27,389 - $63,830
-4,690 Reduced 58.68%
3,302 $19,000
Q4 2021

Feb 14, 2022

BUY
$12.52 - $19.02 $93,799 - $142,497
7,492 Added 1498.4%
7,992 $103,000
Q3 2021

Nov 15, 2021

SELL
$10.47 - $20.87 $1,884 - $3,756
-180 Reduced 26.47%
500 $7,000
Q2 2021

Aug 16, 2021

BUY
$13.9 - $22.58 $1,612 - $2,619
116 Added 20.57%
680 $15,000
Q1 2021

May 13, 2021

SELL
$15.41 - $30.42 $18,183 - $35,895
-1,180 Reduced 67.66%
564 $11,000
Q4 2020

Feb 09, 2021

BUY
$10.17 - $17.12 $71 - $119
7 Added 0.4%
1,744 $25,000
Q3 2020

Nov 05, 2020

BUY
$6.12 - $20.65 $7,509 - $25,337
1,227 Added 240.59%
1,737 $30,000
Q1 2020

May 14, 2020

BUY
$3.5 - $9.74 $1,785 - $4,967
510 New
510 $3,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $23.3M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.